Your browser doesn't support javascript.
loading
Implementing Preexposure Prophylaxis for HIV Prevention in a Statewide Correctional System in the United States.
Murphy, Matthew; Rogers, Brooke G; Ames, Evan; Galipeau, Drew; Uber, Julia; Napoleon, Siena; Brinkley-Rubinstein, Lauren; Toma, Emily; Byrne, Sophie; Teitelman, Anne M; Berk, Justin; Chan, Philip A; Ramsey, Susan.
Afiliação
  • Murphy M; Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
  • Rogers BG; Brown University School of Public Health, Providence, RI, USA.
  • Ames E; Rhode Island Hospital, Providence, RI, USA.
  • Galipeau D; The Rhode Island Department of Corrections, Cranston, RI, USA.
  • Uber J; Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
  • Napoleon S; Brown University School of Public Health, Providence, RI, USA.
  • Brinkley-Rubinstein L; The Miriam Hospital, Providence, RI, USA.
  • Toma E; Rhode Island Hospital, Providence, RI, USA.
  • Byrne S; The Miriam Hospital, Providence, RI, USA.
  • Teitelman AM; Rhode Island Hospital, Providence, RI, USA.
  • Berk J; Brown University School of Public Health, Providence, RI, USA.
  • Chan PA; Duke University, Durham, NC, USA.
  • Ramsey S; Brown University School of Public Health, Providence, RI, USA.
Public Health Rep ; 139(2): 174-179, 2024.
Article em En | MEDLINE | ID: mdl-37476929
HIV disproportionately affects populations experiencing incarceration. Preexposure prophylaxis (PrEP) is an effective approach to preventing HIV acquisition among populations at increased risk of acquiring HIV. Yet few, if any, efforts have been made to offer PrEP in correctional settings. Beginning in November 2019, the Rhode Island Department of Corrections (RIDOC) implemented a systemwide PrEP initiation program with linkage to PrEP care in the community upon reentry. Incarcerated individuals identified as being potentially at increased risk of HIV acquisition during standard clinical screenings and medical care were referred to a PrEP care provider for potential PrEP initiation. Of the 309 people who met with a PrEP care provider, 35% (n = 109; 88 men, 21 women) agreed to initiate PrEP while incarcerated. Clinical testing and evaluation were completed for 82% (n = 89; 69 men, 20 women) of those who agreed to initiate PrEP. Of those, 54% (n = 48; 29 men, 19 women) completed the necessary clinical evaluation to initiate PrEP, were determined to be appropriate candidates for PrEP use, and had the medication delivered to a RIDOC facility for initiation. Only 8 people (4 men, 4 women) were successfully linked to a PrEP care provider in the community after release. The RIDOC experience demonstrates notable levels of PrEP interest and moderate levels of PrEP uptake among this population. However, PrEP engagement in care after release and persistence in taking PrEP when in the community were relatively poor, indicating a need to better understand approaches to overcoming barriers to PrEP care in this unique setting.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prisioneiros / Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição Limite: Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prisioneiros / Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição Limite: Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article